Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.
about
Can serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literatureMicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinomaMicroarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3.Biomarkers for Hepatocellular Carcinoma.A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma.The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer.Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
P2860
Q27023427-0C77D78F-187E-46E7-BE29-9BD8A95A6688Q36411622-44EC4FC6-042C-433F-9B1D-B6AB42C88D19Q37212003-8CC5352F-6EDB-43FD-805D-BEA46B415C01Q38692450-FAD2E15E-E754-49A2-AC9D-EB6D20A0192AQ38703937-BA67316C-446E-4E16-A6B0-FFF17CA3E400Q38730342-CFF77D1A-FE10-4F34-8ED4-34FAF4DF7F81Q39378285-1EF08F3D-344E-4800-AE77-72ACCA304AE3Q41550210-6AA28CD1-9607-47DB-81B0-F76346A067CCQ42176411-2D22D4FC-8BAC-4D18-B3DF-C9CC97796D4BQ50095439-3B6A8C85-C589-4780-90B0-4A01891F9E7CQ51435881-84D9A628-591D-42F1-8965-BEA8124289F6Q55189641-74F18563-85F4-40D7-93BB-F5329E2E3EDD
P2860
Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Development of a clinical chem ...... s of hepatocellular carcinoma.
@en
Development of a clinical chem ...... s of hepatocellular carcinoma.
@nl
type
label
Development of a clinical chem ...... s of hepatocellular carcinoma.
@en
Development of a clinical chem ...... s of hepatocellular carcinoma.
@nl
prefLabel
Development of a clinical chem ...... s of hepatocellular carcinoma.
@en
Development of a clinical chem ...... s of hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Development of a clinical chem ...... is of hepatocellular carcinoma
@en
P2093
Cong-Rong Wang
Juan-Ping Yu
Ming-Song Li
Rui-Juan Ma
Shi-Ni Qin
Wei-Wen Xu
Xi-Guang Xu
Xiao-Bo Wang
P2860
P356
10.1002/JCLA.21733
P577
2014-03-28T00:00:00Z